Introduction to Continuing Medical Education (CME)

A system for Continuing Medical Education (CME) is aimed to assure a high level of theoretic and clinical competence throughout the working life of medical specialists. CME provides educational activities, which allow doctors to maintain, develop and increase medical knowledge and skills and to improve their professional performance to ensure better and safer diagnosis and treatment for the patient.

At present there is no standardised system across Europe for accrediting CME activities and providing credits. Some European countries have established CME systems with a legal obligation to collect a certain number of credits in order to practice medicine, while in other countries no such system exists and CME is considered as an ethical and moral responsibility of each individual practitioner.

In Europe, the Union of European Medical Specialists (UEMS) has established the European Accreditation Council for CME (EACCME), aimed at facilitating the development of a common European CME system. This committee acts as an umbrella structure for the national CME authorities and guarantees the reciprocity of awarded CME credits in different European countries as well as with the American Medical Association (AMA) and the Royal College of Physicians and Surgeons of Canada.

European Board of Accreditation in Allergy and Clinical Immunology (EBAACI)

The UEMS-EACCME sets itself as the central link between the National Accreditation Authorities, the UEMS Specialist Sections and Boards, the European Specialty Accreditation Boards and the Providers of CME activities.

However, the UEMS-EACCME cannot review itself and guarantee the quality of the CME accredited activities. In order to guarantee an independent assessment of educational projects and to warrant sufficient control mechanisms for European scientific standards, EAACI has initiated collaboration between the EAACI’s CME Accreditation Committee, the UEMS Allergology Section and Board, and EACCME. This collaboration has resulted in the implementation of EBAACI (European Board of Accreditation in Allergy and Clinical Immunology).

EBAACI ensures the assessment of a CME programme's scientific quality by a board of European experts in the fields of allergy and clinical immunology. EBAACI reviews all applications for European CME credits in this field.  The assessment certifies that the CME activity has a high quality scientific content and appropriate didactic approach, is free of commercial bias and that the CME provider fulfils the EBAACI quality requirements.
The maximum number of European CME credits  (ECMECs) that may be claimed by a learner must be a minimum of one educational hour, with each hour of educational time expected to count as one ECMEC, up to a maximum of 3 ECMECs for a half day and 6 ECMECs for a full day.

EAACI CME Committee

  CME Committee Chair Jean-Luc Fauquert              WG Biologicals Board Member    Barbara Rogala
  VP Education & Specialty Stefano del Giacco      Asthma Section Chair    Matteo Bonini
  UEMS Allergology SB Chair Roy Gerth van Wijk Dermatology Section    Charlotte Mortz
  UEMS Allergology SB Secretary Norbert Mülleneisen     Immunology Section Board Member Stefanie Eyerich
  ENT Section Chair Ludger Klimek Pediatric Section Chair Helen Brogh
  Interest Group Representative    Jolanta Walusiak-Skorupa

EBAACI Members

  UEMS Members     EAACI Members  
  UEMS Allergology SB Chair Roy Gerth van Wijk             Chair Asthma Section Matteo Bonini
  UEMS Allergology SB Secretary Norbert Mülleneisen   Chair Dermatology Section Charlotte Mortz
  UEMS Allergology SB Treasurer Rik Schrijvers   Board Member Immunology Section Stefanie Eyerich
  UEMS Allergology SB Member Jose Maria Olaguibel Ribero   Chair Pediatrics Section Helen Brough
  UEMS Allergology SB Member Ignacio Jesus Davila Gonzalez   CME Committee Chair Jean-Luc Fauquert

Application Procedure

The accreditation of all CME programmes is performed online through the portal of EACCME.
After a preliminary review by EACCME, all applications are transferred to the EBAACI secretariat for further administrative processing and evaluation of the scientific programme by an independent board of European experts, composed of six members, three from EAACI and three from the UEMS Allergology Section and Board, nominated for four years. EBAACI then recommends the appropriate number of credits to EACCME which will finalise the accreditation process and inform the CME provider of the number of CME credits for their event and provide the required information to issue certificates.
The timescale for the application implies that the completed application form, with all relevant attachments and full payment for the application, is received no less than twelve weeks from the planned start date of the event, and preferably more than 16 weeks.


A pre-defined processing fee applies for both EACCME and EBAACI. For live events, accreditation fees are based on the number of expected participants and is not dependent on the number of European CME credits (ECMECs) awarded.

UEMS - EACCME & EBAACI Sliding scale

Participants Fee
1-250 375€
251-500 675€
501-1000 1000€
1001-2000 1.300€
2001-5000 2.550€
Over 5000 4.400€

To start the application process and view a checklist of required documentation, please click here.
Last updated 29 October 2019
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback